118 related articles for article (PubMed ID: 10756088)
1. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
Roussel V; Yi F; Jauberteau MO; Couderq C; Lacombe C; Michelet V; Gil R; Couratier P; Vallat JM; Preud'homme JL
J Autoimmun; 2000 May; 14(3):259-65. PubMed ID: 10756088
[TBL] [Abstract][Full Text] [Related]
2. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
Lakos G; Teodorescu M
Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.
Mankaï A; Achour A; Thabet Y; Manoubia W; Sakly W; Ghedira I
Pathol Biol (Paris); 2012 Oct; 60(5):291-5. PubMed ID: 21839587
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus.
Gould T; Tikly M; Asherson R; Loizou S; Singh S
Scand J Rheumatol; 2006; 35(1):29-34. PubMed ID: 16467038
[TBL] [Abstract][Full Text] [Related]
6. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions.
Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L
Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690
[TBL] [Abstract][Full Text] [Related]
9. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
11. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
12. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
14. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
15. Real world experience with antiphospholipid antibody tests: how stable are results over time?
Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
18. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2008 Apr; 59(4):561-7. PubMed ID: 18383424
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers.
Nikolova M; Liubomirova M; Iliev A; Krasteva R; Andreev E; Radenkova J; Minkova V; Djerassi R; Kiperova B; Vlahov ID
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):908-10. PubMed ID: 12455177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
